Literature DB >> 11393262

The role of laparoscopy in the diagnosis and treatment of peritoneal carcinomatosis: a case report.

B T Takizawa1, E K Shin, L Masters, F Lancelle, V Anaf, S Shahabi.   

Abstract

A patient presented with deep venous thrombosis and an elevated CA-125 level, but normal pelvic ultrasound and abdominal and pelvic CT scans. Laparoscopy revealed diffuse carcinomatosis and a diagnosis of stage IIIc, poorly differentiated epithelial ovarian carcinoma was made. Laparoscopy may provide an alternative means of diagnosis when conventional imaging fails, and may facilitate the placement of catheters for subsequent intraperitoneal therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393262      PMCID: PMC2588690     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  13 in total

1.  Hemisulfur mustard in the palliation of patients with metastatic ovarian carcinoma.

Authors:  T H GREEN
Journal:  Obstet Gynecol       Date:  1959-04       Impact factor: 7.661

2.  [The place of second-look laparoscopy in monitoring treatment of advanced malignant ovarian neoplasms].

Authors:  A Skret; R Kluza; W Fabisiak
Journal:  Ginekol Pol       Date:  1997-04       Impact factor: 1.232

3.  Second look for ovarian cancer: laparoscopy or Laparotomy? A prospective comparative study.

Authors:  K B Clough; J M Ladonne; C Nos; C Renolleau; P Validire; J C Durand
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

4.  Sonographic detection of peritoneal carcinomatosis: a prospective study of 37 cases.

Authors:  M Rioux; C Michaud
Journal:  Abdom Imaging       Date:  1995 Jan-Feb

5.  Use of CA-125 response to predict survival parameters of patients with advanced ovarian carcinoma.

Authors:  I G Ron; M Inbar; I Gelernter; O Lewysohn; D Ayalon; J Dale; S Chaitchik
Journal:  Acta Obstet Gynecol Scand       Date:  1994-09       Impact factor: 3.636

6.  Monitoring cancer antigen 125 levels in induction chemotherapy for epithelial ovarian carcinoma and predicting outcome of second-look procedure.

Authors:  J J Folk; M Botsford; A G Musa
Journal:  Gynecol Oncol       Date:  1995-05       Impact factor: 5.482

7.  Misstaging of ovarian cancer.

Authors:  L McGowan; L P Lesher; H J Norris; M Barnett
Journal:  Obstet Gynecol       Date:  1985-04       Impact factor: 7.661

8.  Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group.

Authors:  G J Rustin; J N Gennings; A E Nelstrop; H Covarrubias; H E Lambert; K D Bagshawe
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

9.  Staging laparotomy in early ovarian cancer.

Authors:  R C Young; D G Decker; J T Wharton; M S Piver; W F Sindelar; B K Edwards; J P Smith
Journal:  JAMA       Date:  1983-12-09       Impact factor: 56.272

Review 10.  Markers supplementing CA 125 in ovarian cancer.

Authors:  U H Stenman; H Alfthan; J Vartiainen; P Lehtovirta
Journal:  Ann Med       Date:  1995-02       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.